missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Descrizione
Assay 1: Fully biologically active when compared to standard. Measured in a serum-free cell proliferation assay using human MCF-7 cells. The ED50 for this effect is 0.3-1.5 ng/mL, corresponding to a specific activity of > 6.7 x 10^5 U/mg. Assay 2: Fully biologically active when compared to standard. The ED50 as determined by the stimulation of protein synthesis using rat L6 myoblasts is less than 10 ng/mL, corresponding to a specific activity of > 1.0 x 10^5 U/mg.
Specifica
Specifica
| Da utilizzare con (applicazione) | SDS-PAGE, Bioactivity |
| Formulazione | Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH 7.2. |
| ID gene (immissione) | 3479 |
| Peso molecolare | MolecularWeight-theroretical: 9.1 kDa |
| Quantità | 5 mg |
| Requisiti di stoccaggio | Store at -20°C to -70°C as supplied. After reconstitution, store at 2 to 8 C for 1 month and (at -20°C to -70°C for long term storage. Avoid repeated freeze/thaw cycles.) |
| Concentrazione di endotossine | Less than 0.01 EU/μg of IGF-I/IGF-1 AS determined by LAL method. |
| Alias gene | IBP1, IGF1A, IGFI, IGF-I, IGF-IA, IGF-IB, insulin-like growth factor 1, insulin-like growth factor 1 (somatomedin C), insulin-like growth factor I, insulin-like growth factor IA, insulin-like growth factor IB, Mechano growth factor, MGF, somatomedin-C |
| Simbolo del gene | IGF1 |
| Ricostituzione | Recommended to centrifuge prior to opening. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL Apportion stock solutions into working aliquots and store (at <-20°C.) |
| Vedi altri risultati |
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?